DeepMatter collaborates with AstraZeneca to improve productivity of compound synthesis
LONDON: DeepMatter Group has collaborated with AstraZeneca to use innovative digital technologies with the aim of improving the productivity and reproducibility of compound synthesis. DeepMatter’s long term strategy is to integrate chemistry with technology, thereby enabling a greater use of…